Ślusarczyk A, Zapała P, Zapała L, Borkowski T, Radziszewski P (2023) Cancer-specific survival of patients with non-muscle-invasive bladder cancer: a population-based analysis. Ann Surg Oncol 30(12):7892–7902

Article  PubMed  PubMed Central  Google Scholar 

Beijert IJ, Hentschel AE, Bründl J et al (2023) Prognosis of primary papillary Ta Grade 3 bladder cancer in the non–muscle-invasive spectrum. Eur Urol Oncol 6(2):214–221

Article  PubMed  Google Scholar 

Babjuk M, Burger M, Capoun O et al (2022) European Association of Urology guidelines on non–muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ). Eur Urol 81:75–94

Article  PubMed  Google Scholar 

Tan W, Steinberg GK, Witjes JA et al (2022) Intermediate-risk non–muscle-invasive bladder cancer: updated consensus definition and management recommendations from the international bladder cancer group. Eur Urol Oncol 5(5):505–516

Article  PubMed  Google Scholar 

Holzbeierlein J, Bixler BR, Buckley DI et al (2024) Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline: 2024 amendment. J Urol. https://doi.org/10.1097/JU.0000000000003846

Article  PubMed  Google Scholar 

Cumberbatch MGK, Foerster B, Catto JWF et al (2018) Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review. Eur Urol 73(6):925–933

Article  PubMed  Google Scholar 

Gordon P, Thomas FT, Noon AP, Rosario DJ, Catto JWF (2019) Long-term outcomes from re-resection for high-risk non–muscle-invasive bladder cancer: a potential to rationalize use. Eur Urol Focus 5(4):650–657

Article  PubMed  Google Scholar 

Fujikawa A, Yumura Y, Yao M, Tsuchiya F, Iwasaki A, Moriyama M (2012) An evaluation to define the role of repeat transurethral resection in a treatment algorithm for non-muscle-invasive bladder cancer. Indian J Urol 28:267–270

Article  PubMed  PubMed Central  Google Scholar 

Grimm MO, Steinhoff C, Simon X, Spiegelhalder P, Ackermann R, Vogeli TA (2003) Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 170:433–437

Article  PubMed  Google Scholar 

Engelhardt PF, Simak R, Daha LK, Plas E, Pfluger H (2001) Ranking of the 2nd-look transurethral electroresection of the superficial carcinoma of the bladder. Aktuelle Urol 32:173–177

Article  Google Scholar 

Han KS, Joung JY, Cho KS et al (2008) Results of repeated transurethral resection for a second opinion in patients referred for non-muscle invasive bladder cancer: the referral cancer center experience and review of the literature. J Endourol 22:2699–2704

Article  PubMed  Google Scholar 

Herr HW (2005) Restaging transurethral resection of high-risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. J Urol 174:2134–2137

Article  PubMed  Google Scholar 

Hensley PJ, Bree KK, Brooks N et al (2022) Implications of guideline-based, risk-stratified restaging transurethral resection of high-grade ta urothelial carcinoma on Bacillus Calmette-Guérin therapy outcomes. Eur Urol Oncol 5(3):347–356

Article  PubMed  Google Scholar 

Lee K, Jeong S, Yoo SH, Ku JH (2022) Evaluating the efficacy of secondary transurethral resection of the bladder for high-grade Ta tumors. Invest Clin Urol 63(1):14

Article  Google Scholar 

Bentzen HB, Høstmælingen N (2019) Balancing protection and free movement of personal data: the New European Union General Data Protection Regulation. Ann Intern Med 170(5):335

Article  PubMed  Google Scholar 

U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER): BCG- Unresponsive Nonmuscle Invasive Bladder Can- cer: Developing Drugs and Biologics for Treat- ment Guidance for Industry. U.S. Food and Drug Administration 2018. Available at https://www.fda.gov/media/101468/download

Tinay İ, Baltacı S, Demirdağ C et al (2020) Ta grade 3/high grade non-invasive bladder cancer: should we perform a second TUR? Int J Clin Pract. https://doi.org/10.1111/ijcp.13924

Article  PubMed  Google Scholar 

Tully KH, Moschini M, Von Rundstedt FE et al (2020) Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer—examining the utility of classifying Ta bladder cancer based on size. Urol Oncol 38(11):851.e19-851.e25

Article  PubMed  Google Scholar 

Yoneda K, Kamiya N, Utsumi T et al (2021) Impact of lymphovascular invasion on prognosis in the patients with bladder cancer—comparison of transurethral resection and radical cystectomy. Diagnostics 11(2):244

Article  PubMed  PubMed Central  Google Scholar 

Baumeister P, Zamboni S, Mattei A et al (2019) Histological variants in non-muscle invasive bladder cancer. Transl Androl Urol 8(1):34–38

Article  PubMed  PubMed Central  Google Scholar 

Shariat SF, Palapattu GS, Karakiewicz PI et al (2007) Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy. Eur Urol 51(1):152–160

Article  PubMed  Google Scholar 

Matulay JT, Li R, Hensley PJ et al (2021) Contemporary outcomes of patients with nonmuscle-invasive bladder cancer treated with Bacillus Calmette-Guérin: implications for clinical trial design. J Urol 205(6):1612–1621

Article  PubMed  Google Scholar 

Contieri R, Hensley PJ, Tan WS et al (2023) Oncological outcomes for patients with European Association of Urology very high-risk non–muscle-invasive bladder cancer treated with Bacillus Calmette-Guérin or early radical cystectomy. Eur Urol Oncol 6(6):590–596

Article  PubMed  Google Scholar 

Yanagisawa T, Kawada T, Von Deimling M et al (2023) Repeat transurethral resection for non–muscle-invasive bladder cancer: an updated systematic review and meta-analysis in the contemporary era. Eur Urol Focus. https://doi.org/10.1016/j.euf.2023.07.002

Article  PubMed  Google Scholar 

Regnier S, Califano G, Elalouf V et al (2022) Restaging transurethral resection in Ta high-grade nonmuscle invasive bladder cancer: a systematic review. Curr Opin Urol 32(1):54–60

Article  PubMed  Google Scholar 

Herr HW, Sogani PC (2001) Does early cystectomy improve the survival of patients with high-risk superficial bladder tumors? J Urol 166(4):1296–1299

Article  CAS  PubMed  Google Scholar 

Casey RG, Catto JWF, Liu C et al (2015) Diagnosis and management of urothelial carcinoma in situ of the lower urinary tract: a systematic review. Eur Urol 67(5):876–888

Article  PubMed  Google Scholar 

Burger M, Grossman HB, Droller M et al (2013) Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. Eur Urol 64(5):846–854. https://doi.org/10.1016/j.eururo.2013.03.059

Article  PubMed  Google Scholar 

Mariappan P, Finney SM, Head E et al (2012) Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking. BJU Int 109(11):1666–1673. https://doi.org/10.1111/j.1464-410X.2011.10571.x

Article  PubMed  Google Scholar